These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 4734261)

  • 1. Measurement of the third component of complement bound to red blood cells in patients with the cold agglutinin syndrome.
    Logue GL; Rosse WF; Gockerman JP
    J Clin Invest; 1973 Feb; 52(2):493-501. PubMed ID: 4734261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic hemolytic anemia due to cold agglutinins: the mechanism of resistance of red cells to C' hemolysis by cold agglutinins.
    Evans RS; Turner E; Bingham M
    J Clin Invest; 1967 Sep; 46(9):1461-74. PubMed ID: 4166664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic hemolytic anemia due to cold agglutinins. II. The role of C' in red cell destruction.
    Evans RS; Turner E; Bingham M; Woods R
    J Clin Invest; 1968 Apr; 47(4):691-701. PubMed ID: 5641611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. INTERACTIONS BETWEEN 131-I TRACE-LABELLED COLD AGGLUTININ, COMPLEMENT AND RED CELLS.
    HARBOE M
    Br J Haematol; 1964 Jul; 10():339-46. PubMed ID: 14179488
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms of immune lysis of the red cells in hereditary erythroblastic multinuclearity with a positive acidified serum test and paroxysmal nocturnal hemoglobinuria.
    Rosse WF; Logue GL; Adams J; Crookston JH
    J Clin Invest; 1974 Jan; 53(1):31-43. PubMed ID: 4855546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune haemolytic anaemias. V. studies on the resistance against complement haemolysis of the red cells of patients with chronic cold agglutinin disease.
    Engelfriet CP; Von dem Borne AE; Beckers D; Reynierse E; Van Loghem JJ
    Clin Exp Immunol; 1972 Jun; 11(2):255-64. PubMed ID: 4114316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man.
    Jaffe CJ; Atkinson JP; Frank MM
    J Clin Invest; 1976 Oct; 58(4):942-9. PubMed ID: 965497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemolysis in cold agglutinin disease: the role of C' and cell age in red cell destruction.
    Dudok de Wit C; Van Gastel C
    Br J Haematol; 1970 May; 18(5):557-66. PubMed ID: 5430344
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation of complement by cold agglutinins.
    Kirschfink M; Knoblauch K; Roelcke D
    Infusionsther Transfusionsmed; 1994 Dec; 21(6):405-9. PubMed ID: 7873919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia.
    Petz LD; Fink DJ; Letsky EA; Fudenberg HH; Müller-Eberhard J
    J Clin Invest; 1969 Nov; 47(11):2469-84. PubMed ID: 4975569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fixation of the first component of complement (C'la) by human antibodies.
    Rosse WF
    J Clin Invest; 1969 Nov; 47(11):2430-45. PubMed ID: 4180276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement fixation by rheumatoid factor.
    Tanimoto K; Cooper NR; Johnson JS; Vaughan JH
    J Clin Invest; 1975 Mar; 55(3):437-45. PubMed ID: 1078825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The variability of hemolysis in the cold agglutinin syndrome.
    Rosse WF; Adams JP
    Blood; 1980 Sep; 56(3):409-16. PubMed ID: 7407408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells.
    Logue GL; Rosse WF; Adams JP
    J Clin Invest; 1973 May; 52(5):1129-37. PubMed ID: 4700488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of complement in immunohematology.
    Garratty G
    Crit Rev Clin Lab Sci; 1984; 20(1):25-56. PubMed ID: 6373144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemolytic anaemia in the rabbit following the injection of human anti-I cold agglutinins.
    Cooper AG; Brown DL
    Clin Exp Immunol; 1971 Jul; 9(1):99-110. PubMed ID: 5559095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cold agglutinin disease: where do we stand, and where are we going?
    Berentsen S; Malecka A; Randen U; Tjønnfjord GE
    Clin Adv Hematol Oncol; 2020 Jan; 18(1):35-44. PubMed ID: 32511221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations between quantitative assay of red cell-bound C3, serologic reactions, and hemolytic anemia.
    Fischer JT; Petz LD; Garratty G; Cooper NR
    Blood; 1974 Sep; 44(3):359-73. PubMed ID: 4211894
    [No Abstract]   [Full Text] [Related]  

  • 20. The resistance of C'-142 coated cells to complement hemolysis by cold agglutinin.
    Evans RS; Turner E; Bingham M
    Bibl Haematol; 1965; 23():834-9. PubMed ID: 5879447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.